PPD brings extensive experience in the nuances of post-approval studies, combined with a solid foundation in late-stage clinical trials management.
Extensive knowledge of hematology and oncology research, vast capabilities and experience with feasibility studies and a large investigator network.
As clinical trial investigators, physicians play an integral role in the development of life-changing medicines.
Get information about PPD posted on industry websites and publications.
Andres Bayona, executive director in clinical monitoring and regional head of Latin America, and Mercedes Ponce de Leon, senior manager in regulatory affairs, discuss the clinical trial regulatory landscape in Latin America.
Kirsten Messmer, Ph.D., R.A.C., principal regulatory affairs specialist, details changes in regulatory guidelines for first-in-human trials.
Regulatory affairs experts at PPD, Alistair Davidson and Vincenzo Cannizzaro, reflect on how the United Kingdom's departure from the European Union might impact the pharmaceutical industry.
Bill Wang, director of regulatory affairs, discusses China's regulatory environment in the second-largest pharmaceutical market in the world.
We want to hear from you
Register in PPD's Database
© 2018 Pharmaceutical Product Development, LLC. All rights reserved.